Role of brain-derived neurotrophic factor in Huntington's disease
The DOI matches its Crossref record; 341 of the 341 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–341 of 341
Reduced hippocampal neurogenesis in R6/2 transgenic Huntington's disease mice
Gil, J. M. A. C., Mohapel, P., Araújo, I. M., Popovic, N., Li, J.-Y., Brundin, P., & Petersén, Å. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.05.006 · Cited by 167
Haubensak, W., Narz, F., Heumann, R., & Leβmann, V. (1998) · Journal of Cell Science · doi:10.1242/jcs.111.11.1483 · Cited by 167
Sun, Y.-M., Greenway, D. J., Johnson, R., Street, M., Belyaev, N. D., Deuchars, J., Bee, T., Wilde, S., & Buckley, N. J. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-07-0687 · Cited by 166
Gunawardena, S., & Goldstein, L. S. B. (2003) · Journal of Neurobiology · doi:10.1002/neu.10319 · Cited by 164
Bemelmans, A.-P., Horellou, P., Pradier, L., Brunet, I., Colin, P., & Mallet, J. (1999) · Human Gene Therapy · doi:10.1089/10430349950016393 · Cited by 163
Pham, T. M., Söderström, S., Winblad, B., & Mohammed, A. H. (1999) · Behavioural Brain Research · doi:10.1016/s0166-4328(99)00019-4 · Cited by 162 · cited 1×
“In particular, environmental enrichment upregulates neurotrophins such as BDNF and NGF in the hippocampus and cortex (Falkenberg et al., 1992; Young et al., 1999; Pham et al., 1999a,b; Keyvani et al., 2004).”
BackgroundNeurotrophic Factor Receptors and Their Signal Transduction Capabilities in Rat Astrocytes
Rudge, J. S., Li, Y., Pasnikowski, E. M., Mattsson, K., Pan, L., Yancopoulos, G. D., Wiegand, S. J., Lindsay, R. M., & Ip, N. Y. (1994) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1994.tb00981.x · Cited by 162
Upstream Stimulatory Factors Are Mediators of Ca2+-Responsive Transcription in Neurons
Chen, W. G., West, A. E., Tao, X., Corfas, G., Szentirmay, M. N., Sawadogo, M., Vinson, C., & Greenberg, M. E. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-07-02572.2003 · Cited by 161
Immunohistochemical localization of brain-derived neurotrophic factor in adult rat brain
Kawamoto, Y., Nakamura, S., Nakano, S., Oka, N., Akiguchi, I., & Kimura, J. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00245-x · Cited by 161
Down-regulation of the Neurotrophin Receptor TrkB following Ligand Binding
Sommerfeld, M. T., Schweigreiter, R., Barde, Y.-A., & Hoppe, E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8982 · Cited by 161
de Almeida, L. P., Zala, D., Aebischer, P., & Déglon, N. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0388 · Cited by 156
Blöchl, A., & Thoenen, H. (1996) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1996.0014 · Cited by 156
Anderson, K. D., Panayotatos, N., Corcoran, T. L., Lindsay, R. M., & Wiegand, S. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.7346 · Cited by 155
Schmidt‐Kastner, R., Wetmore, C., & OLSON, L. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00093-0 · Cited by 153
Friedman, W., Black, I. B., & Kaplan, D. R. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00526-5 · Cited by 153
Decreased hippocampal cell proliferation in R6/1 Huntington’s mice
Lazic, S. E., Grote, H., Armstrong, R. J. E., Blakemore, C., Hannan, A. J., van Dellen, A., & Barker, R. A. (2004) · NeuroReport · doi:10.1097/00001756-200404090-00014 · Cited by 151
Generation and characterization of embryonic striatal conditionally immortalized ST14A cells
Cattaneo, E. F., & Conti, L. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19980715)53:2<223::aid-jnr11>3.0.co;2-7 · Cited by 148
Self-citationAdenosine receptors and Huntington's disease: implications for pathogenesis and therapeutics
Blum, D., Hourez, R., Galas, M., Popoli, P., & Schiffmann, S. N. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00411-3 · Cited by 148
Ivkovic, S., & Ehrlich, M. E. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-13-05409.1999 · Cited by 147
Mizuta, I., Ohta, M., Ohta, K., Nishimura, M., Mizuta, E., & Kuno, S. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02098-5 · Cited by 145 · cited 5×
“Like memantine, riluzole (a neuroprotective drug commonly used in amyotrophic lateral sclerosis (ALS)) acts by blocking glutamatergic neurotransmission in the CNS. Interestingly, it has also been found to upregulate the levels of a number of key neurotrophic factors, including BDNF and glial-derived neurotrophic facto…”
BackgroundInfluentialTongiorgi, E., Armellin, M., Giulianini, P. G., Bregola, G., Zucchini, S., Paradiso, B., Steward, O., Cattaneo, A., & Simonato, M. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5471-03.2004 · Cited by 143
Kolbeck, R., Bartke, I., Eberle, W., & Barde, Y. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0721930.x · Cited by 141
Wetmore, C., Cao, Y. H., Pettersson, R. F., & Olson, L. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.21.9843 · Cited by 140
Reduced expression of the TrkB receptor in Huntington's disease mouse models and in human brain
Ginés, S., Bosch, M., Marco, S., Gavaldà, N., Díaz‐Hernández, M., Lucas, J. J., Canals, J. M., & Alberch, J. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04590.x · Cited by 140
Fast transport and retrograde movement of huntingtin and HAP 1 in axons
Block-Galarza, J., Chase, K. O., Sapp, E., Vaughn, K. T., Vallee, R. B., DiFiglia, M., & Aronin, N. (1997) · NeuroReport · doi:10.1097/00001756-199707070-00031 · Cited by 139
Tabuchi, A., Nakaoka, R., Amano, K., Yukimine, M., Andoh, T., Kuraishi, Y., & Tsuda, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909538199 · Cited by 138
Decreased cAMP Response Element-mediated Transcription
Sugars, K. L., Brown, R., J. Cook, L., Swartz, J., & Rubinsztein, D. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310226200 · Cited by 137
Lithium suppresses excitotoxicity-induced striatal lesions in a rat model of Huntington’s disease
Wei, H., Qin, Z.-H., Senatorov, V. V., Wei, W., Wang, Y., Qian, Y., & Chuang, D.-M. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00311-6 · Cited by 137
Knüsel, B., Gao, H., Okazaki, T., Yoshida, T., Mori, N., Hefti, F. F., & Kaplan, D. R. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00616-1 · Cited by 136
Bessis, A., Champtiaux, N., Chatelin, L., & Changeux, J.-P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.11.5906 · Cited by 136
Design of Potent Peptide Mimetics of Brain-derived Neurotrophic Factor
O'Leary, P. D., & Hughes, R. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303209200 · Cited by 129
Detection of Brain-derived Neurotrophic Factor in a Vesicular Fraction of Brain Synaptosomes
Fawcett, J. P., Aloyz, R., McLean, J. H., Pareek, S., Miller, F. D., McPherson, P. S., & Murphy, R. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.14.8837 · Cited by 127
Kojima, M., Takei, N., Numakawa, T., Ishikawa, Y., Suzuki, S., Matsumoto, T., Katoh‐Semba, R., Nawa, H., & Hatanaka, H. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1080 · Cited by 127
Canals, J. M., Checa, N., Marco, S., Åkerud, P., Michels, A., Pérez‐Navarro, E., Tolosa, E. S., Arenas, E., & Alberch, J. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-01-00117.2001 · Cited by 126
Ceccatelli, S., Ernfors, P., Villar, M. J., Persson, H., & Hökfelt, T. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.10352 · Cited by 126
Phillips, W., Morton, A. J., & Barker, R. A. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3796-05.2005 · Cited by 124
Structure of the Brain-Derived Neurotrophic Factor/Neurotrophin 3 Heterodimer
Robinson, R. C., Radziejewski, C., Stuart, D. I., & Jones, E. Y. (1995) · Biochemistry · doi:10.1021/bi00013a001 · Cited by 124
Shimojo, M., Paquette, A. J., Anderson, D. J., & Hersh, L. B. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.10.6788 · Cited by 124
Profound and Selective Loss of Catalytic TrkB Immunoreactivity in Alzheimer's Disease
Allen, S. J., Wilcock, G. K., & Dawbarn, D. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1561 · Cited by 123
Fox, J. H., Barber, D. S., Singh, B., Zucker, B., Swindell, M. K., Norflus, F., Buzescu, R., Chopra, R., Ferrante, R. J., Kazantsev, A., et al. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02726.x · Cited by 123
Neurotrophins regulate the function of cultured microglia
Nakajima, K., Kikuchi, Y., Ikoma, E., Honda, S., Ishikawa, M., Liu, Y., & Kohsaka, S. (1998) · Glia · doi:10.1002/(sici)1098-1136(199811)24:3<272::aid-glia2>3.0.co;2-4 · Cited by 122
Trk receptor alterations in Alzheimer's disease
Connor, B. J., Young, D., Lawlor, P. A., Gai, W., Waldvogel, H. J., Faull, R. L. M., & Dragunow, M. (1996) · Molecular Brain Research · doi:10.1016/s0169-328x(96)00040-x · Cited by 121
Timmusk, T., Lendahl, U., Funakoshi, H., Arenas, E., Persson, H., & Metsis, M. (1995) · The Journal of cell biology · doi:10.1083/jcb.128.1.185 · Cited by 121
Huntingtin inclusions do not deplete polyglutamine-containing transcription factors in HD mice
Yu, Z.-X. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.8.905 · Cited by 121
Timmusk, T., Palm, K., Lendahl, U., & Metsis, M. (1999) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)88378-3 · Cited by 120
Depletion of wild‐type huntingtin in mouse models of neurologic diseases
Zhang, Y., Li, M., Drozda, M., Chen, M., Ren, S., Mejia Sanchez, R. O., Leavitt, B. R., Cattaneo, E., Ferrante, R. J., Hayden, M. R., et al. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01980.x · Cited by 120
Self-citationNeurochemistry and toxin models in Huntingtonʼs disease
Beal, M. F. (1994) · Current Opinion in Neurology · doi:10.1097/00019052-199412000-00012 · Cited by 119
Increased GABAergic function in mouse models of Huntington's disease: Reversal by BDNF
Cepeda, C., Starling, A. J., Wu, N., Nguyen, O. K., Uzgil, B., Soda, T., André, V. M., Ariano, M. A., & Levine, M. S. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20344 · Cited by 118
NR2A and NR2B receptor gene variations modify age at onset in Huntington disease
Arning, L., Kraus, P. H., Valentin, S., Saft, C., Andrich, J., & Epplen, J. T. (2004) · Neurogenetics · doi:10.1007/s10048-004-0198-8 · Cited by 118
Domains of the TGN: Coats, Tethers and G Proteins
Gleeson, P. A., Lock, J. G., Luke, M. R., & Stow, J. L. (2004) · Traffic · doi:10.1111/j.1398-9219.2004.00182.x · Cited by 116
BDNF and trkB mRNA expression in the hippocampal formation of aging rats
Lapchak, P. A., Araujo, D. M., Beck, K. D., Finch, C. E., Johnson, S. A., & Hefti, F. F. (1993) · Neurobiology of Aging · doi:10.1016/0197-4580(93)90087-r · Cited by 114
Senatorov, V. V., Ren, M., Kanai, H., Wei, H., & Chuang, D. M. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001463 · Cited by 114
Su, X., Kameoka, S., Lentz, S., & Majumder, S. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.18.8018-8025.2004 · Cited by 113
Guo, Z., Ersoz, A., Butterfield, D. A., & Mattson, M. P. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750314.x · Cited by 109
Timmusk, T., Belluardo, N., Persson, H., & METSIS, M. L. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90242-9 · Cited by 108
Cystamine treatment is neuroprotective in the YAC128 mouse model of Huntington disease
Van Raamsdonk, J. M., Pearson, J., Bailey, C. D. C., Rogers, D. A., Johnson, G. V. W., Hayden, M. R., & Leavitt, B. R. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03357.x · Cited by 107
Li, L., Murphy, T. H., Hayden, M. R., & Raymond, L. A. (2004) · Journal of Neurophysiology · doi:10.1152/jn.00308.2004 · Cited by 107
Saltzman, W. M., Mak, M., Mahoney, M. J., Duenas, E. T., & Cleland, J. L. (1999) · Pharmaceutical Research · doi:10.1023/a:1018824324275 · Cited by 106
Hansson, A. C., Sommer, W. H., Metsis, M., Strömberg, I., Agnati, L. F., & Fuxe, K. (2006) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2005.01390.x · Cited by 104 · cited 1×
“Unlike the other BDNF promoters analysed above, BDNF exon IV promoter contains glucocorticoid-responsive elements (Schaaf et al., 2000, for a review), and its activity is influenced by thyroid hormone (Koibuchi et al., 1999) and corticosterone (Hansson et al., 2006).”
BackgroundThe N-methyl-D-aspartate antagonist memantine retards progression of Huntington’s disease
Beister, A., Kraus, P., Kuhn, W., Dose, M., Weindl, A., & Gerlach, M. (2004) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-0579-5_14 · Cited by 98
Blood—Brain—Cerebrospinal Fluid Barriers
Laterra, J., Keep, R. F., Betz, L. A., & Goldstein, G. W. (1999) · Cited by 98
del Toro, D., Canals, J. M., Ginés, S., Kojima, M., Egea, G., & Alberch, J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3873-06.2006 · Cited by 95
The evidence for the existence of cannabinoid receptors
Pertwee, R. G. (1993) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(93)90154-p · Cited by 95
Immunohistochemical Visualization of Brain‐derived Neurotrophic Factor in the Rat Brain
Dugich‐Djordjevic, M. M., Peterson, C., Isono, F., Ohsawa, F., Widmer, H. R., Denton, T. L., Bennett, G. L., & Hefti, F. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb00703.x · Cited by 95
Environmental, pharmacological, and genetic modulation of the HD phenotype in transgenic mice
Schilling, G., Savonenko, A. V., Coonfield, M. L., Morton, J. L., Vorovich, E. B., Gale, A., Neslon, C., Chan, N., Eaton, M., Fromholt, D., et al. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.01.003 · Cited by 92
Paroxetine retards disease onset and progression in Huntingtin mutant mice
Duan, W., Guo, Z., Jiang, H., Ladenheim, B., Xu, X., Cadet, J. L., & Mattson, M. P. (2004) · Annals of Neurology · doi:10.1002/ana.20075 · Cited by 91
Aberrant amplification of A 2A receptor signaling in striatal cells expressing mutant huntingtin
Varani, K., Rigamonti, D., Sipione, S., Camurri, A., Borea, P. A., Cattabeni, F., Abbracchio, M. P., & Cattaneo, E. (2001) · The FASEB Journal · doi:10.1096/fj.00-0730fje · Cited by 91
Self-citationBailey, C. D. C., & Johnson, G. V. W. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02839.x · Cited by 89
Koibuchi, N., Fukuda, H., & Chin, W. W. (1999) · Endocrinology · doi:10.1210/endo.140.9.6997 · Cited by 87
Ivković, S., Polonskaia, O., Fariñas, I., & Ehrlich, M. E. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00684-7 · Cited by 87
Genetic analysis of learning behavior-induced structural plasticity
Rampon, C., & Tsien, J. Z. (2000) · Hippocampus · doi:10.1002/1098-1063(2000)10:5<605::aid-hipo11>3.0.co;2-3 · Cited by 86
Itoh, K., Hashimoto, K., Kumakiri, C., Shimizu, E., & Iyo, M. (2004) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20078 · Cited by 85
Distinctive four promoters collectively direct expression of brain-derived neurotrophic factor gene
Nakayama, M., Gahara, Y., Kitamura, T., & Ohara, O. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90251-8 · Cited by 85
Riluzole in Huntington's disease (HD): an open label study with one year follow up
Seppi, K., Mueller, J., Bodner, T., Brandauer, E., Benke, T., Weirich‐Schwaiger, H., Poewe, W. H., & Wenning, G. K. (2001) · Journal of Neurology · doi:10.1007/s004150170071 · Cited by 85
Mittoux, V., Ouary, S., Monville, C., Lisovoski, F., Poyot, T., Condé, F., Escartin, C., Robichon, R., Brouillet, E., Peschanski, M., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-11-04478.2002 · Cited by 84
Wood, N. I., & Morton, A. J. (2003) · Brain Research Bulletin · doi:10.1016/s0361-9230(03)00141-2 · Cited by 84
Givalois, L., Marmigère, F., Rage, F., Ixart, G., Arancibia, S., & Tapia-Arancibia, L. (2001) · Neuroendocrinology · doi:10.1159/000054681 · Cited by 83
Conversion of myoblasts to physiologically active neuronal phenotype
Watanabe, Y., Kameoka, S., Gopalakrishnan, V., Aldape, K., Pan, Z. Z., Lang, F. F., & Majumder, S. (2004) · Genes & Development · doi:10.1101/gad.1179004 · Cited by 83
Aberrant A 2A receptor function in peripheral blood cells in Huntington's disease
Varani, K., Abbracchio, M. P., Cannella, M., Cislaghi, G., Giallonardo, P., Mariotti, C., Cattabriga, E., Cattabeni, F., Borea, P. A., Squitieri, F., et al. (2003) · The FASEB Journal · doi:10.1096/fj.03-0079fje · Cited by 82
Self-citationBelyaev, N. D., Wood, I. C., Bruce, A. W., Street, M., Trinh, J.-B., & Buckley, N. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m310353200 · Cited by 81
Zala, D., Benchoua, A., Brouillet, E., Perrin, V., Gaillard, M.-C., Zurn, A. D., Aebischer, P., & Déglon, N. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.05.017 · Cited by 81
Nakao, N., Brundin, P., Funa, K., Lindvall, O., & Odin, P. (1995) · Developmental Brain Research · doi:10.1016/0165-3806(96)83489-4 · Cited by 80
Bishop, J. F., Mueller, G. P., & Mouradian, M. M. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90094-9 · Cited by 78
Tarditi, A., Camurri, A., Varani, K., Borea, P. A., Woodman, B., Bates, G., Cattaneo, E., & Abbracchio, M. P. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.01.014 · Cited by 77
Self-citationFreeland, K., Boxer, L. M., & Latchman, D. S. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00158-9 · Cited by 77
Huntley, G. W., Benson, D. L., Jones, E. G., & Isackson, P. J. (1992) · Developmental Brain Research · doi:10.1016/0165-3806(92)90103-4 · Cited by 76
Neurotrophins, neuroprotection and the blood-brain barrier.
Pardridge, W. M. (2002) · PubMed · Cited by 76
Kallunki, P., Edelman, G. M., & Jones, F. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3233 · Cited by 74
A controlled trial of fluoxetine in nondepressed patients with Huntington's disease
Como, P. G., Rubin, A. J., O'Brien, C. F., Lawler, K., Hickey, C., Rubin, A. E., Henderson, R., McDermott, M. P., McDermott, M., Steinberg, K., et al. (1997) · Movement Disorders · doi:10.1002/mds.870120319 · Cited by 73
Pérez‐Navarro, E., Alberch, J., Neveu, I., & Arenas, E. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00723-4 · Cited by 73
Cognitive Procedural Learning in Patients With Fronto-Striatal Lesions
Schmidtke, K., Manner, H., Kaufmann, R., & Schmolck, H. (2002) · Learning & Memory · doi:10.1101/lm.47202 · Cited by 72
Gene Expression Profiling in the Intact and Injured Brain Following Environmental Enrichment
Keyvani, K., Sachser, N., Witte, O. W., & Paulus, W. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.6.598 · Cited by 71
Hallböök, F., Lundin, L., & Kullander, K. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-21-08700.1998 · Cited by 71
Fusco, F., Zuccato, C., Tartari, M., Martorana, A., DeMarch, Z., Giampà, C., Cattaneo, E., & Bernardi, G. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02844.x · Cited by 70
Self-citationCattaneo, E. F., Magrassi, L., Butti, G., Santi, L. D., Giavazzi, A., & Pezzotta, S. (1994) · Developmental Brain Research · doi:10.1016/0165-3806(94)00137-5 · Cited by 70
Self-citationPineda, J. R., Canals, J. M., Bosch, M., Adell, A., Mengod, G., Artigas, F., Ernfors, P., & Alberch, J. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03047.x · Cited by 69
Differential Regulation of Hippocampal Neurotrophins During Aging in Rats
Narisawa‐Saito, M., & Nawa, H. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67031124.x · Cited by 69
REST/NRSF-Interacting LIM Domain Protein, a Putative Nuclear Translocation Receptor
Shimojo, M., & Hersh, L. B. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.24.9025-9031.2003 · Cited by 68
Zala, D., Bensadoun, J., de Almeida, L. P., Leavitt, B. R., Gutekunst, C., Aebischer, P., Hayden, M. R., & Déglon, N. (2003) · Experimental Neurology · doi:10.1016/j.expneurol.2003.09.002 · Cited by 68
Effects of BDNF and NT‐4/5 on Striatonigral Neuropeptides or Nigral GABA Neurons In Vivo
Arenas, E., Åkerud, P., Wong, V., Boylan, C., Person, H., Lindsay, R. M., & Altar, C. A. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01314.x · Cited by 67
Interaction of the Repressor Element 1-silencing Transcription Factor (REST) with Target Genes
Wood, I. C., Belyaev, N. D., Bruce, A. W., Jones, C., Mistry, M., Roopra, A., & Buckley, N. J. (2003) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.10.017 · Cited by 64
Striatal dopamine output is compromised within +/− BDNF mice
Dluzen, D. E., Anderson, L. I., McDermott, J. L., Kucera, J., & Walro, J. M. (2002) · Synapse · doi:10.1002/syn.10027 · Cited by 62
Subcellular localization of epitope-tagged neurotrophins in neuroendocrine cells
M�ller, J. C., Kr�ttgen, A., Heymach, J. V., Ghori, N., & Shooter, E. M. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19980215)51:4<463::aid-jnr6>3.0.co;2-a · Cited by 61
BDNF‐activated Sianal Transduction in Rat Cortical Glial Cells
Roback, J. D., Marsh, H. N., Downen, M., Palfrey, H. C., & Wainer, B. H. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb01072.x · Cited by 61
Van Dellen, A., Grote, H. E., & Hannan, A. J. (2005) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2005.04313.x · Cited by 59
Savaskan, E., Müller-Spahn, F., Olivieri, G., Bruttel, S., Otten, U., Rosenberg, C., Hulette, C., & Hock, C. (2000) · European Neurology · doi:10.1159/000008229 · Cited by 58
Shimojo, M., & Hersh, L. B. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03608.x · Cited by 58
Rubio, N. (1997) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1997.tb00751.x · Cited by 57
Sauer, H., Campbell, K., Wiegand, S. J., Lindsay, R. M., & Björklund, A. (1994) · NeuroReport · doi:10.1097/00001756-199401000-00019 · Cited by 56
Structure and function of dynactin
Schroer, T. A. (1996) · Seminars in Cell and Developmental Biology · doi:10.1006/scdb.1996.0041 · Cited by 54
Cystamine inhibits transglutaminase and caspase‐3 cleavage in glutamate‐exposed astroglial cells
Ientile, R., Campisi, A., Raciti, G., Caccamo, D., Currò, M., Cannavò, G., Volti, G. L., Macaione, S., & Vanella, A. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10702 · Cited by 52
Canals, J. M., Marco, S., Checa, N., Michels, A., Pérez‐Navarro, E., Arenas, E., & Alberch, J. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0211 · Cited by 51
Furukawa, S., Sugihara, Y., Iwasaki, F., Fukumitsu, H., Nitta, A., Nomoto, H., & Furukawa, Y. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00315-1 · Cited by 51
Analysis on the promoter region of exon IV brain‐derived neurotrophic factor in NG108‐15 cells
Takeuchi, Y., Miyamoto, E., & Fukunaga, K. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01096.x · Cited by 47
Giampà, C., DeMarch, Z., D’Angelo, V., Morello, M., Martorana, A., Sancesario, G., Bernardi, G., & Fusco, F. R. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04545.x · Cited by 47
Organization, sequence and functional analysis of a mouse BDNF promoter
Hayes, V. Y., Towner, M. D., & Isackson, P. J. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(96)00254-9 · Cited by 47
The S18Y polymorphism in the UCHL1 gene is a genetic modifier in Huntington’s disease
Metzger, S., Bauer, P. O., Tomiuk, J., Laccone, F. A., DiDonato, S., Gellera, C., Soliveri, P., Lange, H. W., Weirich‐Schwaiger, H., Wenning, G. K., et al. (2005) · Neurogenetics · doi:10.1007/s10048-005-0023-z · Cited by 47
Novel monocyclic and bicyclic loop mimetics of brain-derived neurotrophic factor
Fletcher, J. M., & Hughes, R. A. (2006) · Journal of Peptide Science · doi:10.1002/psc.760 · Cited by 45
Remotivation Therapy and Huntingtonʼs Disease
Sullivan, F. R., Bird, E. D., Alpay, M., & Cha, J.-H. J. (2001) · Journal of Neuroscience Nursing · doi:10.1097/01376517-200106000-00005 · Cited by 45
Role of neurotrophins in preventing glutamate induced neuronal cell death
Lindholm, D. (1994) · Journal of Neurology · doi:10.1007/bf00939234 · Cited by 44
Genetic analysis of candidate genes modifying the age-at-onset in Huntington’s disease
Metzger, S., Bauer, P., Tomiuk, J., Laccone, F. A., DiDonato, S., Gellera, C., Mariotti, C., Lange, H. W., Weirich‐Schwaiger, H., Wenning, G. K., et al. (2006) · Human Genetics · doi:10.1007/s00439-006-0221-2 · Cited by 42
Characterization of the nuclear targeting signal of REST/NRSF
Shimojo, M. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.12.080 · Cited by 40
Soontornniyomkij, V., Wang, G., Pittman, C. A., Hamilton, R. L., Wiley, C. A., & Achim, C. L. (1999) · Acta Neuropathologica · doi:10.1007/s004010051092 · Cited by 40
Transglutaminases - Possible Drug Targets in Human Diseases
Gentile, V., & Cooper, A. J. L. (2004) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007043482552 · Cited by 39
Effects of acute paroxetine administration on tryptophan metabolism and disposition in the rat
Badawy, A. A. ‐., & Morgan, C. J. (1991) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1991.tb12190.x · Cited by 39
Association between BDNF Val66Met polymorphism and age at onset in Huntington disease
Alberch, J., López, M., Badenas, C., Carrasco, J. L., Milà, M., Muñoz, E., & Canals, J. M. (2005) · Neurology · doi:10.1212/01.wnl.0000175977.57661.b1 · Cited by 39
6-Hydroxydopamine lesions reduce BDNF mRNA levels in adult rat brain substantia nigra
Venero, J. L., Beck, K. D., & Hefti, F. (1994) · NeuroReport · doi:10.1097/00001756-199401120-00014 · Cited by 36
Takeuchi, Y., Yamamoto, H., Miyakawa, T., & Miyamoto, E. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741913.x · Cited by 35
Brain-derived neurotrophic factor does not influence age at neurologic onset of Huntington’s disease
Kishikawa, S., Li, J., Gillis, T., Hakky, M. M., Warby, S. C., Hayden, M. R., MacDonald, M. E., Myers, R. H., & Gusella, J. F. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.07.008 · Cited by 35
Canals, J. M., Checa, N., Marco, S., Michels, A., Pérez‐Navarro, E., & Alberch, J. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00130-8 · Cited by 34
Transglutaminase and diseases of the central nervous system.
Hoffner, G., & Djian, P. (2005) · Frontiers in Bioscience · doi:10.2741/1764 · Cited by 33
Up-regulation of trkB mRNA expression in the rat striatum after seizures
Salin, T., Mudò, G., Jiang, X. H., Timmusk, T., METSIS, M. L., & Belluardo, N. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11772-o · Cited by 31
Kawamoto, Y., Nakamura, S., Kawamata, T., Akiguchi, I., & Kimura, J. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01082-3 · Cited by 27
Wetmore, C., Cao, Y., Pettersson, R. F., & Olson, L. (1993) · Journal of Histochemistry & Cytochemistry · doi:10.1177/41.4.8450192 · Cited by 24
No evidence of association between BDNF gene variants and age-at-onset of Huntington's disease
Maria, E. D., Marasco, A., Tartari, M., Ciotti, P., Abbruzzese, G., Novelli, G., Bellone, E., Cattaneo, E. F., & Mandich, P. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.07.002 · Cited by 23
Self-citationTrkB and TrkC Are Differentially Regulated by Excitotoxicity during Development of the Basal Ganglia
Checa, N., Canals, J. M., Gratacòs, E., & Alberch, J. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7796 · Cited by 17
Rite, I., Machado, A., Cano, J., & Venero, J. L. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.11.005 · Cited by 11
From target identification to drug screening assays for neurodegenerative diseases
Zuccato, C., Tartari, M., Goffredo, D., Cattaneo, E. F., & Rigamonti, D. (2005) · Pharmacological Research · doi:10.1016/j.phrs.2005.03.010 · Cited by 9
Self-citationRole of Neurotrophic Factors in Cerebral Ischemia
Nikolics, K. (1999) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-59920-0_9 · Cited by 3
Increased activity of surviving locus ceruleus neurons in Alzheimer's disease
Moser (1999) · Pure Amsterdam UMC · doi:10.1002/1531-8249(199901)45:1
(1999) · doi:10.1002/(sici)1097-4547(19990915)57:6<830::aid-jnr8>3.0.co;2-2
Cited by
Brain-derived neurotrophic factor in neurodegenerative diseases
Zuccato, C., & Cattaneo, E. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.54 · Cited by 947
Self-citationMolecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease
Zuccato, C., Valenza, M., & Cattaneo, E. (2010) · Physiological Reviews · doi:10.1152/physrev.00041.2009 · Cited by 848
“Biological and molecular findings have linked wild-type huntingtin to BDNF, a neurotrophin that is particularly important for the survival of striatal neurons and for the activity of the cortico-striatal synapses (668).”
BackgroundInfluentialSelf-citationPruunsild, P., Kazantseva, A., Aid, T., Palm, K., & Timmusk, T. (2007) · Genomics · doi:10.1016/j.ygeno.2007.05.004 · Cited by 699
Ribeiro, J. A., & Sebastião, A. M. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1379 · Cited by 577
Adenosine receptors and brain diseases: neuroprotection and neurodegeneration
Gomes, C. V., Kaster, M. P., Tomé, A. R., Agostinho, P. M., & Cunha, R. A. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.12.001 · Cited by 419
“HD [202].”
Metadata
- Authors
- ZUCCATO, C., & CATTANEO, E.
- Venue
- Progress in Neurobiology
- Publisher
- Elsevier BV
- Published
- 2007-04
- Volume
- 81
- Issue
- 5-6
- Pages
- 294-330
- ISSN
- 0301-0082 (ISSN-L)
- OpenAlex
- W2143935514
- Cited by
- 552
- References
- 341
- FWCI
- 11.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.